Anti-Atrophic Effects of Dichotomine B from Stellaria dichotoma During Starvation-Induced Skeletal Muscle Atrophy
Molecules · 2025
DOI: 10.3390/molecules30183839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jae-Yong Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Muscular Atrophy, Plant Extracts, Muscle, Skeletal. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Basic Science Research Program through the National Research Foundation of Korea.
Abstract (Originalsprache)
Muscle atrophy is defined as reductions in muscle size and function and represents a critical concern affecting elderly populations, immobilized patients, and individuals following specific dietary regimens, such as fasting and low-protein diets. This study investigated the protective effects of Stellaria dichotoma root extract and its isolated bioactive compounds during muscle atrophy using both in vitro and in vivo experimental models. First, S. dichotoma root extract prevented dexamethasone (DEX)-induced atrophy in C2C12 myotubes. Through systematic solvent partitioning and resin chromatography, five compounds (1–5) were successfully isolated from the n-butanol fraction. Dichotomine B (2) was identified as the most abundant and bioactive constituent. Treatment with dichotomine B significantly preserved the myotube diameter, enhanced the fusion index, and maintained the myosin heavy chain protein level while suppressing key atrophic biomarkers, including FoxO3a, MuRF-1, and Atrogin-1, in DEX-treated myotubes. Furthermore, dichotomine B (2) reduced proteolysis in serum-free cultured C2C12 myotubes and in mice subjected to 48 h of fasting, preserving muscle mass and strength. These findings suggest that S. dichotoma root extract and its principal compound, dichotomine B (2), have promising therapeutic potential and provide an opportunity to develop novel pharmacological interventions against muscle wasting through suppression of proteolysis pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea.
- Lifecare Center, Huons N Co., Ltd., Gwacheon-si 13840, Gyeonggi-do, Republic of Korea.
- Rural Development Administration (RDA), Eumseong-gun 27709, Chungcheongbuk-do, Republic of Korea.
ORCID-Profile: Uttapol Permpoon, Ji Hoon Kim, Chul Young Kim
Förderung
- National Research Foundation of Korea
- Basic Science Research Program through the National Research Foundation of Korea
Zitieren
APA
Kim, J. Y., Permpoon, U., Lee, J. H., Kim, J. H., Kim, H. M., Jeon, J. S., Nam, T. G., & Kim, C. Y. (2025). Anti-Atrophic Effects of Dichotomine B from Stellaria dichotoma During Starvation-Induced Skeletal Muscle Atrophy. Molecules. https://doi.org/10.3390/molecules30183839
Vancouver
Kim JY, Permpoon U, Lee JH, Kim JH, Kim HM, Jeon JS, et al. Anti-Atrophic Effects of Dichotomine B from Stellaria dichotoma During Starvation-Induced Skeletal Muscle Atrophy. Molecules. 2025. doi:10.3390/molecules30183839
BibTeX
@article{Kim2025,
author = {Kim, Jae-Yong and Permpoon, Uttapol and Lee, Ju-Hee and Kim, Ji Hoon and Kim, Hye Mi and Jeon, Je-Seung and Nam, Tae-Gyu and Kim, Chul Young},
title = {Anti-Atrophic Effects of Dichotomine B from Stellaria dichotoma During Starvation-Induced Skeletal Muscle Atrophy},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30183839}
}
EUVIMED